illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Airsculpt Technologies
Company logo

Airsculpt Technologies | Sustainability Performance

https://airsculpt.com/

Offers body contouring procedures using proprietary minimally invasive medical technologies.

2012

United States

201 - 500 employees

Medical Device

$100M - 500M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9088
Overall
#2031
in United States
#133
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

100 out of 174

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Arcturus Therapeutics

United States, Health Care, Biotechnology


Company logo
Pivot Bio

United States, Health Care, Biotechnology


Company logo
Cumberland Pharmaceuticals

United States, Health Care, Pharmaceuticals

Market cap

298.0M $, 2026▼28.9% YoY

Revenue

180.0M $, 2024▲8.3% YoY

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

298.0M $, 2026▼28.9% YoY

Revenue

180.0M $, FY2024▲8.3% YoY

EBITDA

10.0M $, FY2024▼9.1% YoY

Operating margin

-1% Industry: -147▼574.1% YoY

P/E ratio

-36.3 Industry: 32▲161.6% YoY

Revenue & EBITDA

$180.0MFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Revenue by region


Revenue by region %

Non-US

Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-2.7M 2024▼628.3% YoY

Capex

14.0M 2024▼35.7% YoY

Debt/equity ratio

0.9 Industry: 1▼NaN% YoY

Return on invested capital

-5.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.2

▼ 2.6%

2022

0.2

▼ 2.7%

2023

0.2

▼ 4.4%

2024

0.2

2028

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

56%
Independent Directors

5 out of 9 incl. management

Powered by illuminem

Overall score

42

Environment

48

Social

36

Governance

44

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email